Literature DB >> 30854812

[Effect of down-regulation of sex determining region Y-box 9 on epithelial mesenchymal transition and cloning of oral squamous carcinoma cells].

Wen-Li Yang1, Ming-Lei Sun1, Peng Zhang1, Wei-Wei Yu1, Hai-Xia Zhou1, Qiang Sun1.   

Abstract

OBJECTIVE: To investigate the effect of sex determining region Y-box 9 (SOX9) on epithelial mesenchymal transition (EMT) and cloning of oral squamous cell carcinoma (OSCC).
METHODS: siRNA control, SOX9 siRNA were transfected into BcaCD885 cells in OSCC. Simultaneously, cells that did not undergo transfection were used as the control. Quantitative real time polymerase chain reaction (qRT-PCR) and Western blot were used to select SOX9 siRNA1 with enhanced interference effect. A cell cloning assay was used to determine the cell's clone formation ability. E-cadherin and Vimentin expressions were detected by immunofluorescence. The expressions of E-cadherin, matrix metalloprotease 2 (MMP-2), Vimentin and matrix metalloprotease 9 (MMP-9) were detected by Western blot. Cell invasion and migration were detected in the Transwell compartment.
RESULTS: The levels of SOX9 mRNA and protein in SOX9 siRNA cells were significantly lower than those of the control (P<0.05). An increase in the number of SOX9 siRNA1 cell clonesled to the considerable decrease of the number of cell invasion and migration. In addition, levels of MMP-2 and MMP-9 proteins in cells decreased significantly compared with the control (P<0.05). The level of Vimentin expression in SOX9 siRNA1 cells decreased, and expression level of E-cadherin was elevated. Cell EMT was inhibited compared with the control, and the difference was statistically significant (P<0.05).
CONCLUSIONS: Down-regulation of SOX9 inhibited EMT, clonogenic formation, cell invasion and OSCC migration.

Entities:  

Keywords:  cell clones; epithelial mesenchymal transition; oral squamous cell carcinoma; sex determining region Y-box 9

Mesh:

Substances:

Year:  2019        PMID: 30854812      PMCID: PMC7030727          DOI: 10.7518/hxkq.2019.01.003

Source DB:  PubMed          Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi        ISSN: 1000-1182


  20 in total

1.  Correction: miR145 Targets the SOX9/ADAM17 Axis to Inhibit Tumor-Initiating Cells and IL6-Mediated Paracrine Effects in Head and Neck Cancer.

Authors: 
Journal:  Cancer Res       Date:  2015-06-16       Impact factor: 12.701

2.  miR-592 functions as a tumor suppressor in human non-small cell lung cancer by targeting SOX9.

Authors:  Zhihong Li; Bai Li; Liang Niu; Liang Ge
Journal:  Oncol Rep       Date:  2016-11-25       Impact factor: 3.906

Review 3.  The network of epithelial-mesenchymal transition: potential new targets for tumor resistance.

Authors:  Danupon Nantajit; Dong Lin; Jian Jian Li
Journal:  J Cancer Res Clin Oncol       Date:  2014-10-01       Impact factor: 4.553

4.  Clinical implication of Sox9 and activated Akt expression in pancreatic ductal adenocarcinoma.

Authors:  Suhua Xia; Zhenyu Feng; Xiaowei Qi; Yuan Yin; Jianqiang Jin; Yufeng Wu; Haorong Wu; Yizhong Feng; Min Tao
Journal:  Med Oncol       Date:  2014-11-27       Impact factor: 3.064

5.  Recurrence prediction in oral cancers: a serum Raman spectroscopy study.

Authors:  Aditi Sahu; Nikhila Nandakumar; Sharada Sawant; C Murali Krishna
Journal:  Analyst       Date:  2015-04-07       Impact factor: 4.616

6.  Prospero homeobox 1 promotes epithelial-mesenchymal transition in colon cancer cells by inhibiting E-cadherin via miR-9.

Authors:  Mei-Hsuan Lu; Chao-Cheng Huang; Mei-Ren Pan; Hong-Hwa Chen; Wen-Chun Hung
Journal:  Clin Cancer Res       Date:  2012-10-08       Impact factor: 12.531

7.  Testis development in the absence of SRY: chromosomal rearrangements at SOX9 and SOX3.

Authors:  Annalisa Vetro; Mohammad Reza Dehghani; Lilia Kraoua; Roberto Giorda; Silvana Beri; Laura Cardarelli; Maurizio Merico; Emmanouil Manolakos; Alexis Parada-Bustamante; Andrea Castro; Orietta Radi; Giovanna Camerino; Alfredo Brusco; Marjan Sabaghian; Crystalena Sofocleous; Francesca Forzano; Pietro Palumbo; Orazio Palumbo; Savino Calvano; Leopoldo Zelante; Paola Grammatico; Sabrina Giglio; Mohamed Basly; Myriam Chaabouni; Massimo Carella; Gianni Russo; Maria Clara Bonaglia; Orsetta Zuffardi
Journal:  Eur J Hum Genet       Date:  2014-11-05       Impact factor: 4.246

8.  E-cadherin re-expression shows in vivo evidence for mesenchymal to epithelial transition in clonal metastatic breast tumor cells.

Authors:  Katie Palen; James Weber; Michael B Dwinell; Bryon D Johnson; Ramani Ramchandran; Jill A Gershan
Journal:  Oncotarget       Date:  2016-07-12

9.  Interplay between Notch1 and Notch3 promotes EMT and tumor initiation in squamous cell carcinoma.

Authors:  Mitsuteru Natsuizaka; Kelly A Whelan; Shingo Kagawa; Koji Tanaka; Veronique Giroux; Prasanna M Chandramouleeswaran; Apple Long; Varun Sahu; Douglas S Darling; Jianwen Que; Yizeng Yang; Jonathan P Katz; E Paul Wileyto; Devraj Basu; Yoshiaki Kita; Shoji Natsugoe; Seiji Naganuma; Andres J Klein-Szanto; J Alan Diehl; Adam J Bass; Kwok-Kin Wong; Anil K Rustgi; Hiroshi Nakagawa
Journal:  Nat Commun       Date:  2017-11-24       Impact factor: 14.919

10.  MicroRNA-101 inhibits proliferation, migration and invasion of human glioblastoma by targeting SOX9.

Authors:  Nan Liu; Lei Zhang; Zhen Wang; Yingduan Cheng; Pengxing Zhang; Xin Wang; Weihong Wen; Hongwei Yang; Hui Liu; Weilin Jin; Yongsheng Zhang; Yanyang Tu
Journal:  Oncotarget       Date:  2017-03-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.